在日本,非癌症的绝症患者在家中的息镇静率
Moyuru Shionozaki1, Ryo Yamamoto2, Jun Hamano3
1Department of General Practice, Saku Central Hospital, 197 Usuda, Saku, Nagano, Japan. moyuru718@gmail.com.
BMC palliative care
|June 4, 2025
概括
在日本,对在家治疗的非癌症患者进行息镇静治疗是不常见的,妄想和呼吸障碍是治疗的主要症状. 这项研究澄清了它在这个人群中的使用.
科学领域:
- 老年医学 老年医学
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
背景情况:
- 在家庭癌症患者的息镇静被记录在案.
- 关于在家治疗的非癌症患者的息镇静的数据有限.
- 了解非癌症患者的镇静实践对于全面的终身护理至关重要.
研究的目的:
- 为了确定日本家庭非癌症患者的息镇静的频率.
- 在这个人口群体中确定需要息镇静的主要症状.
- 为老年非癌症患者提供关于终身护理的见解.
主要方法:
- 一个多中心前性队列研究的后期分析.
- 包括在日本接受家庭护理或在养老院的老年非癌症患者 (≥65岁).
- 从2020年1月到2020年12月收集数据,并进行例行症状和治疗评估.
主要成果:
- 785名患者中有195人死于家中或在养老院.
- 在死亡前给了7名患者 (3.6%) 缓解镇静剂.
- 妄想和呼吸障碍是息镇静的主要目标症状.
结论:
- 在家庭非癌症患者中,息镇静的发生率很低.
- 痴呆症和呼吸障碍是这种人群中以息镇静治疗管理的主要症状.
- 这些发现强调了针对非癌症患者量身定制的息护理策略的必要性.
相关概念视频
Continuing Care
1.6K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Documentation in Long-Term and Home Healthcare Setting
994
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
994
Sedatives and Hypnotics Drugs: Miscellaneous Agents
249
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
249
Sedatives and Hypnotics: Overview
697
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
697
Parenteral Anesthetics: Overview
212
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
212
Sedatives and Hypnotics Drugs: Barbiturates
511
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
511

![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
